Naproxen
Product Images NDC 53002-3101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 53002-3101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Naproxinnastructure (Naproxinnastructure)

Naproxinnastructure (Naproxinnastructure)
Chemical structure of Naproxen showing its molecular arrangement including a naphthalene ring with an ether group, a carboxylate group bonded to a chiral carbon, and a sodium ion.*
FDA Label Image

Naproxinstructure (Naproxinstructure)

Naproxinstructure (Naproxinstructure)
Chemical structure diagram of Naproxen, showing its molecular configuration including aromatic rings, a methoxy group, and a carboxylic acid functional group.*
FDA Label Image

Label Image (Lbl530023101)

Label Image (Lbl530023101)
Naproxen 375 mg tablets package label from RPK Pharmaceuticals, Inc. The label indicates 30 tablets, with directions to take one tablet twice a day or as directed. It includes standard regulatory and barcode information, along with placeholders for clinic and prescriber details.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.